⌘K

Login Start Free

Home/Insiders/Janku Filip

JF

SEC Insider//CIK 0001862930

Janku Filip

CIK 00018629301 companyBOSTON, MA

Transactions

12

Companies

1

Filings

9

CIK

0001862930

Recent Transactions

12 trades

Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-05$15.17/sh−3,155→ 75,026 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-01-02+139,000→ 139,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-02+31,000→ 78,181 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-01-02+161,000→ 161,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2025-01-02+36,000→ 45,189 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-09-13+30,000→ 30,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-01-02+121,000→ 121,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-01-03+135,000→ 135,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-12-15+36,000→ 36,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-10-31+36,000→ 36,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-03-01+86,500→ 86,500 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+387,069→ 387,069 total

Companies

1

Monte Rosa Therapeutics, Inc.
Chief Medical Officer
$GLUE

Recent Filings

9

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118

View on SEC.gov